Pancreatic Cancer Research

ResearcherShanghai Jiao Tong UniversityNo recent work listed

Yuanchi Weng

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-2808-6240; OpenAlex author ID A5019056298. Sources: OpenAlex.

Their work

Papers
15
Trials
0
Grants
0
Labs led
0
Collaborators
31
Papers, trials and grants by year

2015: 1 paper · 2016: none · 2017: none · 2018: 1 paper · 2019: 5 papers · 2020: 1 paper · 2021: 2 papers · 2022: 4 papers · 2023: 1 paper

Papers 15

  1. The Impact of Additional Para-aortic Dissection During Pancreaticoduodenectomy for Resectable Pancreatic Cancer. Co-author DOI 10.1245/s10434-022-12700-z↗
  2. Robotic versus open pancreaticoduodenectomy with vascular resection for pancreatic ductal adenocarcinoma: surgical and oncological outcomes from pilot experien… Co-author DOI 10.1007/s00423-021-02364-w↗
  3. Clinical characteristics and surgical outcomes of resectable acinar cell carcinoma of the pancreas-propensity score matching analysis with pancreatic ductal ad… Co-author DOI 10.1016/j.ejso.2021.11.135↗
  4. Oncological outcomes of robotic pancreatectomy in patients with pancreatic cancer who receive adjuvant chemotherapy: A propensity score-matched retrospective c… Co-author DOI 10.1016/j.ijsu.2022.106801↗
  5. Identification of EMT-related alternative splicing event of TMC7 to promote invasion and migration of pancreatic cancer. Co-author DOI 10.3389/fimmu.2022.1089008↗
  6. Worth it or not? Primary tumor resection for stage IV pancreatic cancer patients: A SEER-based analysis of 15,836 cases. Co-author DOI 10.1002/cam4.4147↗
  7. Oncological outcomes of robotic-assisted versus open pancreatoduodenectomy for pancreatic ductal adenocarcinoma: a propensity score-matched analysis. Co-author DOI 10.1007/s00464-020-07791-2↗
  8. Construction and integrated analysis of a lncRNA-associated competing endogenous RNA network reveal functional lncRNAs in pancreatic cancer. Co-author DOI 10.21037/tcr.2020.04.03↗
  9. Long non-coding RNA LINC01133 silencing exerts antioncogenic effect in pancreatic cancer through the methylation of DKK1 promoter and the activation of Wnt sig… Co-author DOI 10.1080/15384047.2018.1529110↗
  10. Comparison of Radical Antegrade Modular Pancreatosplenectomy with Standard Retrograde Pancreatosplenectomy for Left-Sided Pancreatic Cancer: A Meta-Analysis an… Co-author DOI 10.12659/msm.914540↗
  11. TRIANGLE operation for borderline resectable pancreatic cancer in total pancreatectomy. Co-author DOI 10.21037/tcr.2019.09.50↗
  12. A new enhanced recovery after surgery pathway for left-sided pancreatic cancer patients after distal pancreatectomy. Co-author DOI 10.21037/tcr.2019.10.26↗
  13. PRPF40A as a potential diagnostic and prognostic marker is upregulated in pancreatic cancer tissues and cell lines: an integrated bioinformatics data analysis. Co-author DOI 10.2147/ott.s206039↗
  14. EZH2-Mediated microRNA-139-5p Regulates Epithelial-Mesenchymal Transition and Lymph Node Metastasis of Pancreatic Cancer. Co-author DOI 10.14348/molcells.2018.0109↗
  15. Outcomes of robotic surgery for pancreatic ductal adenocarcinoma. Co-author DOI 10.3978/j.issn.1000-9604.2015.05.05↗

Closest collaborators

The 25 strongest of 31 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Xiaxing Deng · 11 shared papers, 2015–2023 · strength 1.47
  2. Baiyong Shen · 9 shared papers, 2015–2023 · strength 1.10
  3. Chenghong Peng · 6 shared papers, 2015–2023 · strength 0.78
  4. Jiabin Jin · 5 shared papers, 2015–2022 · strength 0.61
  5. Zhen Huo · 5 shared papers, 2019–2021 · strength 0.54
  6. Ziyun Shen · 3 shared papers, 2022–2023 · strength 0.49
  7. Haoda Chen · 3 shared papers, 2022–2023 · strength 0.49
  8. Hao Qian · 4 shared papers, 2019–2022 · strength 0.47
  9. Weishen Wang · 3 shared papers, 2020–2023 · strength 0.45
  10. Shuyu Zhai · 4 shared papers, 2019–2020 · strength 0.40
  11. Shulin Zhao · 3 shared papers, 2019–2022 · strength 0.38
  12. Baiyong Shen · 2 shared papers, 2022 · strength 0.35
  13. Jun Zhang · 2 shared papers, 2022–2023 · strength 0.31
  14. Georgios Gemenetzis · 2 shared papers, 2022 · strength 0.31
  15. Yu Jiang · 2 shared papers, 2021 · strength 0.29
  16. Ningzhen Fu · 2 shared papers, 2021 · strength 0.29
  17. Jin Ma · 2 shared papers, 2018–2019 · strength 0.26
  18. Jiancheng Wang · 2 shared papers, 2018–2019 · strength 0.26
  19. Xiaxing Deng · 2 shared papers, 2019–2020 · strength 0.22
  20. Xiaomei Tang · 2 shared papers, 2019 · strength 0.19
  21. Yuchen Ji · 1 shared paper, 2023 · strength 0.17
  22. Yiran Zhou · 1 shared paper, 2023 · strength 0.17
  23. Xinjing Wang · 1 shared paper, 2022 · strength 0.16
  24. Kai Qin · 1 shared paper, 2022 · strength 0.14
  25. Jun Zhang Zhang · 1 shared paper, 2019 · strength 0.14

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.